“…Technologies laboratories under an early technology access programme, as described recently. 22,26,27 ROI selection and subsequent statistical and correlative analyses were undertaken in the Australian Cancer Research Foundation translational research laboratory. Briefly, a multiplexed cocktail of primary antibodies, each with a unique, UV-photocleavable indexing oligo (Table 1), mouse anti-human CD3E antibody clone UMAB54 (Origene Technologies, Inc., Rockville, MD) conjugated to AF647 using AF647 antibody labelling kit (Thermo Fisher Scientific, Waltham, MA), rabbit anti-human CD45 antibody clone D9M81 (Cell Signalling Technology, Inc., Danvers, MA) conjugated to AF594 using AF594 antibody labelling kit (Thermo Fisher Scientific) and Syto83 nucleic acid stain (Thermo Fisher Scientific), was applied to a slide-mounted BM trephine tissue section.…”